Egis Pharmaceuticals invested a total of HUF 15,263 mil in 2012, down 0.67% compared to the previous year. Historically, between 2003 - 2012, the company's investments stood at a high of HUF 15,366 mil in 2011 and a low of HUF 7,122 mil in 2003.
As a percentage of total sales, investments stood at 11.5% in 2012, down from 11.9% as seen in the previous year. This is compared to an average of 12.1% over the last five years.
As far as Egis Pharmaceuticals's peers are concerned, Gedeon Richter invested HUF 26,617 mil, or 8.15% of its sales in 2012. Comparable figures for Krka are EUR 145 mil and 12.7%.
You can see all the company’s data at Egis Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
